Reuters logo
BRIEF-Shenyang Xingqi Pharmaceutical sees 2017 Q1 to Q3 net profit to decrease by 6.1 pct to 9.9 pct
October 13, 2017 / 2:28 PM / in 10 days

BRIEF-Shenyang Xingqi Pharmaceutical sees 2017 Q1 to Q3 net profit to decrease by 6.1 pct to 9.9 pct

Oct 13 (Reuters) - Shenyang Xingqi Pharmaceutical Co Ltd :

* Sees net profit for 2017 Q1 to Q3 to decrease by 6.1 percent to 9.9 percent, or to be 40.9 million yuan to 42.6 million yuan, compared to net profit of 2016 Q1 to Q3 (45.4 million yuan)

* Says increased operating revenue and R&D expenses as main reason for the forecast

Source text in Chinese: goo.gl/CvWFkP

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below